Evaxion Biotech
(NASDAQ:EVAX)
$3.11
0.11[3.67%]
Last update: 12:27PM Get Real Time Here
Q4 2023 Earnings were released on Wed Mar 27th, before the market open
Consensus Rating1
Buy
Highest Price Target1
$14.00
Lowest Price Target1
$14.00
Consensus Price Target1
$8.00

Evaxion Biotech Stock (NASDAQ:EVAX), Analyst Ratings, Price Targets, Predictions

Evaxion Biotech AS has a consensus price target of $8, established from looking at the 6 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and Ladenburg Thalmann on March 20, 2024, February 12, 2024, and December 21, 2023. With an average price target of $9.33 between HC Wainwright & Co., HC Wainwright & Co., and Ladenburg Thalmann, there's an implied 200.11% upside for Evaxion Biotech AS from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Dec 23
1
Feb
1
Mar
1
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Ladenburg Thalmann
Lake Street
Oppenheimer

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Evaxion Biotech

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
03/20/2024EVAXBuy Now
Evaxion Biotech
$3.11350.16%HC Wainwright & Co.
Swayampakula Ramakanth
→ $14ReiteratesBuy → BuyGet Alert
02/12/2024EVAXBuy Now
Evaxion Biotech
$3.11350.16%HC Wainwright & Co.
Swayampakula Ramakanth
→ $14Initiates → BuyGet Alert
12/21/2023EVAXBuy Now
Evaxion Biotech
$3.11Ladenburg Thalmann
Ahu Demir
DowngradeBuy → NeutralGet Alert
03/31/2023EVAXBuy Now
Evaxion Biotech
$3.11125.08%Lake Street
Thomas Flaten
$180 → $70MaintainsBuyGet Alert
11/17/2022EVAXBuy Now
Evaxion Biotech
$3.11253.7%Oppenheimer
Jeff Jones
$160 → $110MaintainsOutperformGet Alert
07/18/2022EVAXBuy Now
Evaxion Biotech
$3.11414.47%Oppenheimer
Jeff Jones
→ $160Assumes → OutperformGet Alert

FAQ

Q

What is the target price for Evaxion Biotech (EVAX)?

A

The latest price target for Evaxion Biotech (NASDAQ: EVAX) was reported by HC Wainwright & Co. on March 20, 2024. The analyst firm set a price target for $14.00 expecting EVAX to rise to within 12 months (a possible 350.16% upside). 4 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Evaxion Biotech (EVAX)?

A

The latest analyst rating for Evaxion Biotech (NASDAQ: EVAX) was provided by HC Wainwright & Co., and Evaxion Biotech reiterated their buy rating.

Q

When was the last upgrade for Evaxion Biotech (EVAX)?

A

There is no last upgrade for Evaxion Biotech.

Q

When was the last downgrade for Evaxion Biotech (EVAX)?

A

The last downgrade for Evaxion Biotech AS happened on December 21, 2023 when Ladenburg Thalmann changed their price target from N/A to N/A for Evaxion Biotech AS.

Q

When is the next analyst rating going to be posted or updated for Evaxion Biotech (EVAX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Evaxion Biotech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Evaxion Biotech was filed on March 20, 2024 so you should expect the next rating to be made available sometime around March 20, 2025.

Q

Is the Analyst Rating Evaxion Biotech (EVAX) correct?

A

While ratings are subjective and will change, the latest Evaxion Biotech (EVAX) rating was a reiterated with a price target of $0.00 to $14.00. The current price Evaxion Biotech (EVAX) is trading at is $3.11, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch